Quest Diagnostics, Inc. (DGX)
242.76
-1.85
(-0.76%)
USD |
NYSE |
Aug 28, 16:00
242.77
+0.01
(+0.00%)
After-Hours: 20:00
Quest Diagnostics Free Cash Flow : 1.349B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.349B |
| March 31, 2026 | 1.326B |
| December 31, 2025 | 1.359B |
| September 30, 2025 | 1.393B |
| June 30, 2025 | 1.224B |
| March 31, 2025 | 1.056B |
| December 31, 2024 | 909.00M |
| September 30, 2024 | 1.023B |
| June 30, 2024 | 875.00M |
| March 31, 2024 | 947.00M |
| December 31, 2023 | 864.00M |
| September 30, 2023 | 596.00M |
| June 30, 2023 | 878.00M |
| March 31, 2023 | 864.00M |
| December 31, 2022 | 1.314B |
| September 30, 2022 | 1.464B |
| June 30, 2022 | 1.552B |
| March 31, 2022 | 1.602B |
| December 31, 2021 | 1.83B |
| September 30, 2021 | 1.872B |
| June 30, 2021 | 2.171B |
| March 31, 2021 | 2.068B |
| December 31, 2020 | 1.587B |
| September 30, 2020 | 1.384B |
| June 30, 2020 | 816.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 779.00M |
| December 31, 2019 | 843.00M |
| September 30, 2019 | 811.00M |
| June 30, 2019 | 929.00M |
| March 31, 2019 | 938.00M |
| December 31, 2018 | 817.00M |
| September 30, 2018 | 914.00M |
| June 30, 2018 | 892.00M |
| March 31, 2018 | 876.00M |
| December 31, 2017 | 923.00M |
| September 30, 2017 | 858.00M |
| June 30, 2017 | 799.00M |
| March 31, 2017 | 824.00M |
| December 31, 2016 | 776.00M |
| September 30, 2016 | 777.00M |
| June 30, 2016 | 697.00M |
| March 31, 2016 | 657.00M |
| December 31, 2015 | 547.00M |
| September 30, 2015 | 584.00M |
| June 30, 2015 | 593.00M |
| March 31, 2015 | 610.00M |
| December 31, 2014 | 630.00M |
| September 30, 2014 | 550.82M |
| June 30, 2014 | 517.39M |
| March 31, 2014 | 438.85M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Labcorp Holdings, Inc. | 1.155B |
| DaVita, Inc. | 1.610B |
| OPKO Health, Inc. | -134.02M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | -7.355M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 597.00M |
| Cash from Investing (Quarterly) | -134.00M |
| Cash from Financing (Quarterly) | -229.00M |
| Free Cash Flow Per Share (Quarterly) | 4.098 |
| Free Cash Flow to Equity (Quarterly) | 482.00M |
| Free Cash Flow to Firm (Quarterly) | 495.17M |
| Free Cash Flow Yield | 4.95% |